Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives $75.56 Consensus Price Target from Brokerages
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen analysts that are currently covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has assigned a strong […]
More Stories
Nexstar Media Group (NASDAQ:NXST) Price Target Cut to $198.00
Nexstar Media Group (NASDAQ:NXST – Get Free Report) had its price target lowered by analysts at Guggenheim from $200.00 to...
Critical Survey: Cybin (CYBN) versus Its Rivals
Cybin (NYSE:CYBN – Get Free Report) is one of 443 publicly-traded companies in the “Biotechnology” industry, but how does it...
Nuvalent (NASDAQ:NUVL) PT Raised to $125.00
Nuvalent (NASDAQ:NUVL – Get Free Report) had its target price hoisted by equities research analysts at JPMorgan Chase & Co....
Baidu, Inc. (NASDAQ:BIDU) Given Consensus Rating of “Moderate Buy” by Brokerages
Baidu, Inc. (NASDAQ:BIDU – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eighteen brokerages that...
NRG Energy, Inc. (NYSE:NRG) Receives Average Recommendation of “Hold” from Brokerages
NRG Energy, Inc. (NYSE:NRG – Get Free Report) has been given an average recommendation of “Hold” by the eight ratings...
NIKE (NYSE:NKE) Price Target Cut to $77.00
NIKE (NYSE:NKE – Free Report) had its target price cut by JPMorgan Chase & Co. from $80.00 to $77.00 in...